Novartis announces T-Charge™, next-generation CAR-T platform with first-in-human data at ASH 2021

NEXT STORY
Harpoon Therapeutics Provides Pipeline Update for TriTAC® Clinical Programs and T Cell Engager Platforms   
PREV STORY
EUROBIO SCIENTIFIC obtains CE marking for its proprietary test for Covid-19 screening and detection of the Omicron and Delta variants
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vaccinex Reports Third Quarter 2018 Financial Results and Provides Corporate Update

Lead candidate pepinemab (VX15) being evaluated in three ongoing clinical trials in cancer and ...

author_avatar
NASDAQ Market News

Asia-Pacific hand sanitizer market Size to reach USD 770 million by 2026

author_avatar
NASDAQ Market News

Franciosi Consulting Investigating Beta-Adrenergic Receptor Antagonists as Potential New Treatments for Essential Tremor

author_avatar
NASDAQ Market News